Relay Therapeutics, Inc. (RLAY) Investor Relations Documents

Relay Therapeutics, Inc. (RLAY) investor relations documents from the company's IR site: 17 press releases. Read in-app with summaries. First-party data.

Investor relations documents — source: company IR site

Published	Type	Document
2026-08-06	Press release	Relay Therapeutics Reports Second Quarter 2026 Financial Results and Corporate Updates
2026-07-30	Press release	Relay Therapeutics to Announce Second Quarter 2026 Financial Results and Corporate Highlights on August 6, 2026
2026-05-27	Press release	Relay Therapeutics to Participate in Two Upcoming Investor Conferences in June
2026-05-20	Press release	Relay Therapeutics Announces Pricing of Public Offering of Common Stock
2026-05-19	Press release	Relay Therapeutics Announces Proposed Public Offering of Common Stock
2026-05-19	Press release	Relay Therapeutics Announces Initial Clinical Data Demonstrating That Zovegalisib Has Potential for Differentiated Safet
2026-05-05	Press release	Relay Therapeutics Reports First Quarter 2026 Financial Results and Corporate Updates
2026-04-29	Press release	Relay Therapeutics to Announce First Quarter 2026 Financial Results and Corporate Highlights on May 5, 2026
2026-04-27	Press release	Relay Therapeutics Announces Clinical Data for Zovegalisib plus Atirmociclib Triplet Combination Supportive of Further D
2026-04-02	Press release	Relay Therapeutics to Present Initial Clinical Data on Zovegalisib in Vascular Anomalies at the International Society fo
2026-03-16	Press release	Relay Therapeutics Announces Data from Zovegalisib + Fulvestrant at the Phase 3 Dose of 400mg BID Fed at ESMO Targeted A
2026-02-23	Press release	Relay Therapeutics to Participate in Two Upcoming Investor Conferences in March
2026-02-04	Press release	Relay Therapeutics to Participate in Guggenheim Emerging Outlook: Biotech Summit 2026
2026-02-03	Press release	Relay Therapeutics Announces Zovegalisib Granted Breakthrough Therapy Designation by U.S. FDA for PIK3CA-mutant, HR+/HER
2020-01-06	Press release	Press release
	Press release	Relay Therapeutics to Present at the 38th Annual J.P. Morgan Healthcare Conference
	Press release	Foundation Medicine and Relay Therapeutics Collaborate to Develop FoundationOne®CDx as a Companion Diagnostic for Relay’

RLAY overview · RLAY earnings · RLAY financials · RLAY KPIs · RLAY ownership · RLAY peers · RLAY filings

Documents published by the company on its investor-relations site; summaries are model-written. Not personalized investment advice.